{"id":"NCT03656926","sponsor":"Zambon SpA","briefTitle":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","officialTitle":"A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Double Lung Transplant","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-26","primaryCompletion":"2024-03-12","completion":"2024-03-12","firstPosted":"2018-09-04","resultsPosted":"2025-07-24","lastUpdate":"2025-07-24"},"enrollment":169,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Bronchiolitis Obliterans","Chronic Rejection of Lung Transplant","Lung Transplant Rejection","Lung Transplant; Complications","Lung Transplant Failure and Rejection","Chronic Lung Allograft Dysfunction"],"interventions":[{"type":"DRUG","name":"Liposomal Cyclosporine A","otherNames":["L-CsA"]},{"type":"DRUG","name":"Standard of Care","otherNames":["SoC"]}],"arms":[{"label":"L-CsA treatment plus SoC","type":"EXPERIMENTAL"},{"label":"Standard of Care","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of this trial was to assess the efficacy and safety of aerosolized liposomal cyclosporine A (L-CsA) as add-on therapy to standard of care (SoC) as compared to SoC alone in double lung transplant (DLT) recipients with chronic lung allograft dysfunction (CLAD)-bronchiolitis obliterans syndrome (BOS).","primaryOutcome":{"measure":"Mean Change in FEV1 (mL) From Baseline to Week 48","timeFrame":"Week 48","effectByArm":[{"arm":"L-CsA Treatment Plus SoC - FAS","deltaMin":-0.096,"sd":0.112},{"arm":"Standard of Care - FAS","deltaMin":-0.067,"sd":0.1147}],"pValues":[{"comp":"OG000 vs OG001","p":"0.6639"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":39,"countries":["United States","Austria","Belgium","Denmark","France","Germany","Israel","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":46,"n":84},"commonTop":["COVID-19","Disease progression","Cough","Nasopharyngitis","Dyspnoea"]}}